Liquidia (LQDA) Cash from Investing Activities (QoQ) (2020 - 2026)
Liquidia (LQDA) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Liquidia | 6.31 Bn | 6.03 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -332.33% |
| Mar 31, 2026 | 29.92% |
| Dec 31, 2025 | -343.25% |
| Sep 30, 2025 | 13.81% |
| Jun 30, 2025 | -220.30% |
| Mar 31, 2025 | 93.10% |
| Dec 31, 2024 | -173.61% |
| Sep 30, 2024 | -35.43% |
| Jun 30, 2024 | -106.73% |
| Mar 31, 2024 | -202.91% |
| Dec 31, 2023 | 98.03% |
| Sep 30, 2023 | -4,210.70% |
| Jun 30, 2023 | 33.24% |
| Mar 31, 2023 | 25.87% |
| Dec 31, 2022 | -422.34% |
| Sep 30, 2022 | -4,600.00% |
| Jun 30, 2021 | 32.69% |
| Mar 31, 2021 | -105.41% |
| Dec 31, 2020 | 884.51% |
| Sep 30, 2020 | 70.00% |